0000000000638124

AUTHOR

Begoña Porta-oltra

showing 2 related works from this author

Physico-Chemical Stability of Admixtures of Vinflunine Used in Clinical Practice.

2021

Procedure of administration of vinflunine is complex and consists of an Y-site injection with fluid at different speeds. Dose is diluted with 100 mL of 0.9% sodium chloride or 5% glucose and infused with half of the 500 mL bag of the fluid over 20 min; after that, the remaining fluid is administered at 300 mL/h. In this study, chemical stability and physical compatibility of vinflunine diluted with in 500 mL of both fluids were evaluated to simplify the administration procedure (infusion of mixture on 20 min followed by 250 mL of fluid at 300 mL/h). Physical compatibility and chemical stability were evaluated at two temperatures and protected from and exposed to light. Physical compatibilit…

SodiumPharmaceutical ScienceExpiration datechemistry.chemical_element02 engineering and technologySodium ChlorideVinblastine030226 pharmacology & pharmacy03 medical and health scienceschemistry.chemical_compound0302 clinical medicineDrug StabilityChromatography High Pressure LiquidChromatographyVinflunineChemistryTemperatureVinflunine021001 nanoscience & nanotechnologyDilutionClinical PracticeAdministrationGravimetric analysisChemical stability0210 nano-technologyChemical stabilityPhysical compatibilityJournal of pharmaceutical sciences
researchProduct

Effect of Age on Systemic Exposure and Haematological Toxicity of Carboplatin in Advanced Non-Small Cell Lung Cancer Patients

2011

The aim of this study was to evaluate systemic exposure to carboplatin and its haematological toxicity in patients with advanced non-small cell lung cancer both older and younger than 70 years when the target area under the curve (AUC) in elderly patients was reduced by 20%. For this purpose, a population pharmacokinetic model was developed and the haema- tological toxicity of the drug was assessed. A total of 33 patients received carboplatin on day 1 and gemcitabine (1250 mg ⁄ m 2 ) on days 1 and 8. This schedule was repeated every 21 days. The Calvert-Crokcoft-Gault formula was employed to calculate a dose of carboplatin with a target AUC of 5 mg ⁄ min. ⁄ mL in patients under 70 years and…

Pharmacologyeducation.field_of_studymedicine.medical_specialtyChemotherapybusiness.industrymedicine.medical_treatmentPopulationArea under the curveGeneral MedicineNeutropeniaToxicologymedicine.diseaseGastroenterologyCarboplatinGemcitabineSurgerychemistry.chemical_compoundchemistryInternal medicineToxicitymedicineLung cancerbusinesseducationmedicine.drugBasic & Clinical Pharmacology & Toxicology
researchProduct